In a notice on its website, the European Medicines Agency also announced the withdrawal, which means that Vaxzevria is no longer authorized to be marketed or sold in European Union countries.
... a new meta-analysis of six randomized controlled trials in JAMA Neurology finds no increase in seizures in the month following COVID vaccination.
...
The findings suggest that there is no difference in risk of seizure incidence among vaccinated individuals vs placebo recipients," the authors concluded. "However, the risk of seizure occurrence after SARS-CoV-2 infection seems to be relatively high."
Moreover, 60.8% expressed being more willing to get vaccinated for diseases other than COVID-19 as a result of their experiences during the pandemic, while 23.1% reported being less willing. ...
The most widely circulating COVID variant worldwide is now JN.1, having overtaken the XBB family that is the target of the most recent vaccines, the European Medicines Agency said.
The analysis also found that spikes in the number of negative tweets coincided with announcements from governments and health care authorities about vaccination.
While it found that global uptake of at least one COVID-19 vaccine dose was robust, a new survey published in Nature Medicine revealed mixed signals about the current acceptance of vaccines generally, especially COVID-19 boosters. ...
"The repercussions of pandemic disruptions in health care services, the effects of the inequitable and slow global vaccine distribution, and the prevalence of misinformation and mistrust in health authorities continue to be felt," says Jeffrey V. Lazarus, Professor of Global Health at CUNY SPH, head of the Health Systems Research Group at Barcelona Institute for Global Health, and coordinator of the study.
A new study coming out of York University's Centre for Disease Modelling in the Faculty of Science shows that immunity after a COVID-19 booster lasts much longer than the primary series alone. These findings are among other—sometimes "unintuitive"—revelations of how factors like age, sex and comorbidities do and don't affect immune response.
The work is published in the journal Scientific Reports.
